ENO1 and pulmonary fibrosis: Taken together, our results indicated pro-inflammatory and pro-fibrotic roles of cell surface (or extracellular) ENO1 in pulmonary fibrosis, which might provide rationales to explain the efficacy of HL217 observed in bleomycin-treated fibrotic mice.